Talpaz M - Search Results

1

Asciminib monotherapy in patients with chronic-phase chronic myeloid leukemia with the T315I mutation after ≥1 prior tyrosine kinase inhibitor: 2-year follow-up results.

Cortes JE, Sasaki K, Kim DW, Hughes TP, Etienne G, Mauro MJ, Hochhaus A, Lang F, Heinrich MC, Breccia M, Deininger M, Goh YT, Janssen JJWM, Talpaz M, de Soria VGG, le Coutre P, DeAngelo DJ, Damon A, Cacciatore S, Polydoros F, Agrawal N, Rea D. Cortes JE, et al. Among authors: talpaz m. Leukemia. 2024 Jul;38(7):1522-1533. doi: 10.1038/s41375-024-02278-8. Epub 2024 May 16. Leukemia. 2024. PMID: 38755421 Free PMC article. Clinical Trial.

2

Minimal residual disease in interferon-treated chronic myelogenous leukemia: results and pitfalls of analysis based on polymerase chain reaction.

Dhingra K, Kurzrock R, Kantarjian H, Baine R, Eastman PS, Ku S, Gutterman JU, Talpaz M. Dhingra K, et al. Among authors: talpaz m. Leukemia. 1992 Aug;6(8):754-60. Leukemia. 1992. PMID: 1640725

3

Appearance of acute leukemia-associated P190BCR-ABL in chronic myelogenous leukemia may correlate with disease progression.

Dhingra K, Talpaz M, Kantarjian H, Ku S, Rothberg J, Gutterman JU, Kurzrock R. Dhingra K, et al. Among authors: talpaz m. Leukemia. 1991 Mar;5(3):191-5. Leukemia. 1991. PMID: 2013978

4

Serum levels of interleukin-10 in patients with diffuse large cell lymphoma: lack of correlation with prognosis.

Cortes JE, Talpaz M, Cabanillas F, Seymour JF, Kurzrock R. Cortes JE, et al. Among authors: talpaz m. Blood. 1995 May 1;85(9):2516-20. Blood. 1995. PMID: 7537119 Free article.

5

Philadelphia chromosome-negative chronic myelogenous leukemia with rearrangement of the breakpoint cluster region. Long-term follow-up results.

Cortes JE, Talpaz M, Beran M, O'Brien SM, Rios MB, Stass S, Kantarjian HM. Cortes JE, et al. Among authors: talpaz m. Cancer. 1995 Jan 15;75(2):464-70. doi: 10.1002/1097-0142(19950115)75:2<464::aid-cncr2820750209>3.0.co;2-e. Cancer. 1995. PMID: 7812917

6

Role of interleukin-1 inhibitory molecules in therapy of acute and chronic myelogenous leukemia.

Estrov Z, Kurzrock R, Talpaz M. Estrov Z, et al. Among authors: talpaz m. Leuk Lymphoma. 1993 Aug;10(6):407-18. doi: 10.3109/10428199309148197. Leuk Lymphoma. 1993. PMID: 8401177 Review.

7

Result of interferon-alpha therapy in patients with chronic myelogenous leukemia 60 years of age and older.

Cortes J, Kantarjian H, O'Brien S, Robertson LE, Pierce S, Talpaz M. Cortes J, et al. Among authors: talpaz m. Am J Med. 1996 Apr;100(4):452-5. doi: 10.1016/s0002-9343(97)89522-8. Am J Med. 1996. PMID: 8610733 Clinical Trial.

8

Chronic myelogenous leukemia: a review.

Cortes JE, Talpaz M, Kantarjian H. Cortes JE, et al. Among authors: talpaz m. Am J Med. 1996 May;100(5):555-70. doi: 10.1016/s0002-9343(96)00061-7. Am J Med. 1996. PMID: 8644769 Review.

9

Practical guidelines for the management of chronic myelogenous leukemia with interferon alpha.

O'Brien S, Kantarjian H, Talpaz M. O'Brien S, et al. Among authors: talpaz m. Leuk Lymphoma. 1996 Oct;23(3-4):247-52. doi: 10.3109/10428199609054827. Leuk Lymphoma. 1996. PMID: 9031105 Review.

10

Apoptosis in chronic myelogenous leukemia: studies of stage-specific differences.

Gisslinger H, Kurzrock R, Wetzler M, Tucker S, Kantarjian H, Robertson B, Talpaz M. Gisslinger H, et al. Among authors: talpaz m. Leuk Lymphoma. 1997 Mar;25(1-2):121-33. doi: 10.3109/10428199709042502. Leuk Lymphoma. 1997. PMID: 9130620

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

604 results

Search Page

Filters